• GSK sells psoriasis/dermatitis therapy to Dermavant pharmatimes
    July 16, 2018
    Tapinarof is an investigational therapeutic aryl hydrocarbon receptor modulating agent (TAMA) which has been evaluated as a topical therapy in multiple Phase I and Phase II studies involving over 800 human subjects.
PharmaSources Customer Service